Cargando…
Myelomatous ascites and pleural effusion in relapsed multiple myeloma
Extramedullary multiple myeloma is seen in advanced and aggressive disease and occurs due to plasma cell infiltration of sites other than the bone marrow. Myelomatous ascites or pleural effusion is seen in less than 1% of cases and can be differentiated from infectious etiologies based on fluid cyto...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810939/ https://www.ncbi.nlm.nih.gov/pubmed/35140947 http://dx.doi.org/10.1002/ccr3.5329 |
_version_ | 1784644335310995456 |
---|---|
author | Baksh, Mizba Li, Ke Jiang, Liuyan Alegria, Victoria Sher, Taimur Roy, Vivek Chanan‐Khan, Asher Ailawadhi, Sikander Parrondo, Ricardo D. Alhaj Moustafa, Muhamad |
author_facet | Baksh, Mizba Li, Ke Jiang, Liuyan Alegria, Victoria Sher, Taimur Roy, Vivek Chanan‐Khan, Asher Ailawadhi, Sikander Parrondo, Ricardo D. Alhaj Moustafa, Muhamad |
author_sort | Baksh, Mizba |
collection | PubMed |
description | Extramedullary multiple myeloma is seen in advanced and aggressive disease and occurs due to plasma cell infiltration of sites other than the bone marrow. Myelomatous ascites or pleural effusion is seen in less than 1% of cases and can be differentiated from infectious etiologies based on fluid cytology. |
format | Online Article Text |
id | pubmed-8810939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88109392022-02-08 Myelomatous ascites and pleural effusion in relapsed multiple myeloma Baksh, Mizba Li, Ke Jiang, Liuyan Alegria, Victoria Sher, Taimur Roy, Vivek Chanan‐Khan, Asher Ailawadhi, Sikander Parrondo, Ricardo D. Alhaj Moustafa, Muhamad Clin Case Rep Case Reports Extramedullary multiple myeloma is seen in advanced and aggressive disease and occurs due to plasma cell infiltration of sites other than the bone marrow. Myelomatous ascites or pleural effusion is seen in less than 1% of cases and can be differentiated from infectious etiologies based on fluid cytology. John Wiley and Sons Inc. 2022-02-02 /pmc/articles/PMC8810939/ /pubmed/35140947 http://dx.doi.org/10.1002/ccr3.5329 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Reports Baksh, Mizba Li, Ke Jiang, Liuyan Alegria, Victoria Sher, Taimur Roy, Vivek Chanan‐Khan, Asher Ailawadhi, Sikander Parrondo, Ricardo D. Alhaj Moustafa, Muhamad Myelomatous ascites and pleural effusion in relapsed multiple myeloma |
title | Myelomatous ascites and pleural effusion in relapsed multiple myeloma |
title_full | Myelomatous ascites and pleural effusion in relapsed multiple myeloma |
title_fullStr | Myelomatous ascites and pleural effusion in relapsed multiple myeloma |
title_full_unstemmed | Myelomatous ascites and pleural effusion in relapsed multiple myeloma |
title_short | Myelomatous ascites and pleural effusion in relapsed multiple myeloma |
title_sort | myelomatous ascites and pleural effusion in relapsed multiple myeloma |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810939/ https://www.ncbi.nlm.nih.gov/pubmed/35140947 http://dx.doi.org/10.1002/ccr3.5329 |
work_keys_str_mv | AT bakshmizba myelomatousascitesandpleuraleffusioninrelapsedmultiplemyeloma AT like myelomatousascitesandpleuraleffusioninrelapsedmultiplemyeloma AT jiangliuyan myelomatousascitesandpleuraleffusioninrelapsedmultiplemyeloma AT alegriavictoria myelomatousascitesandpleuraleffusioninrelapsedmultiplemyeloma AT shertaimur myelomatousascitesandpleuraleffusioninrelapsedmultiplemyeloma AT royvivek myelomatousascitesandpleuraleffusioninrelapsedmultiplemyeloma AT chanankhanasher myelomatousascitesandpleuraleffusioninrelapsedmultiplemyeloma AT ailawadhisikander myelomatousascitesandpleuraleffusioninrelapsedmultiplemyeloma AT parrondoricardod myelomatousascitesandpleuraleffusioninrelapsedmultiplemyeloma AT alhajmoustafamuhamad myelomatousascitesandpleuraleffusioninrelapsedmultiplemyeloma |